Serial Galectin-3 and Future Cardiovascular Disease in the General Population

Heart - United Kingdom
doi 10.1136/heartjnl-2015-308975
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Role of Galectin-3 in Heart Failure and Cardiovascular Disease

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2019English

Potential Novel Biomarkers of Cardiovascular Dysfunction and Disease: Cardiotrophin-1, Adipokines and Galectin-3

Archives of Medical Science
Medicine
2017English

Dysglycemia and Cardiovascular Risk in the General Population

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Cardiovascular Disease in General Practice

American Journal of the Medical Sciences
Medicine
1939English

Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population: The Multi-Ethnic Study of Atherosclerosis

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2014English

Galectin-3

Science-Business eXchange
2010English

Plasma Copeptin and Chronic Kidney Disease Risk in 3 European Cohorts From the General Population

JCI insight
Medicine
2018English

Traditional Cardiovascular Disease Risk Factors in Dialysis Patients Compared With the General Population: The CHOICE Study

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2002English

Galectin-3

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy